| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,845 |
2,787 |
$158K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
474 |
382 |
$12K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
383 |
289 |
$10K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
187 |
157 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
194 |
165 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
426 |
321 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
371 |
194 |
$1K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
176 |
132 |
$556.13 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,071 |
671 |
$516.42 |
| 20553 |
|
13 |
12 |
$415.21 |
| 80305 |
|
12 |
12 |
$71.83 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
574 |
316 |
$66.70 |
| J3490 |
Unclassified drugs |
676 |
414 |
$59.96 |
| Q3014 |
Telehealth originating site facility fee |
43 |
29 |
$35.27 |
| 36415 |
Collection of venous blood by venipuncture |
33 |
27 |
$19.79 |